{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 31193
    }
  },
  "results": [
    {
      "safetyreportversion": "3",
      "safetyreportid": "10003860",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20150720",
      "reporttype": "1",
      "serious": "1",
      "seriousnesshospitalization": "1",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20150331",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-BAYER-2014-035493",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "BAYER",
        "duplicatenumb": "US-BAYER-2014-035493"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "25",
        "patientonsetageunit": "801",
        "patientagegroup": "5",
        "patientweight": "49.89",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Injury"
          },
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "General physical health deterioration"
          },
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Cerebrovascular arteriovenous malformation",
            "reactionoutcome": "1"
          },
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Gastrooesophageal reflux disease"
          },
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Peripheral artery thrombosis"
          },
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Pain"
          },
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Anxiety"
          },
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Abdominal pain"
          },
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Emotional distress"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "2",
            "medicinalproduct": "AMITRIPTYLINE",
            "drugstructuredosagenumb": "25",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "25 MG, ONCE AT NIGHT",
            "drugindication": "NECK PAIN",
            "activesubstance": {
              "activesubstancename": "AMITRIPTYLINE"
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "YAZ",
            "drugauthorizationnumb": "021676",
            "drugdosagetext": "UNK",
            "drugdosageform": "FILM-COATED TABLET",
            "drugstartdateformat": "610",
            "drugstartdate": "200804",
            "drugenddateformat": "610",
            "drugenddate": "200807",
            "actiondrug": "1",
            "activesubstance": {
              "activesubstancename": "DROSPIRENONE\\ETHINYL ESTRADIOL"
            },
            "openfda": {
              "application_number": [
                "NDA021676"
              ],
              "brand_name": [
                "YAZ"
              ],
              "generic_name": [
                "DROSPIRENONE AND ETHINYL ESTRADIOL"
              ],
              "manufacturer_name": [
                "Bayer HealthCare Pharmaceuticals Inc."
              ],
              "product_ndc": [
                "50419-405"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "rxcui": [
                "630734",
                "748797",
                "748798",
                "748856"
              ],
              "spl_id": [
                "4f14f9c9-411b-48b0-a3d3-cac639cdfb8b"
              ],
              "spl_set_id": [
                "065f33e4-b587-4e66-b896-ca9ab7b7c876"
              ],
              "package_ndc": [
                "50419-405-03"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "REOPRO",
            "activesubstance": {
              "activesubstancename": "ABCIXIMAB"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ACIPHEX",
            "drugstructuredosagenumb": "20",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "2",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "20 MG, BID",
            "drugindication": "GASTROOESOPHAGEAL REFLUX DISEASE",
            "activesubstance": {
              "activesubstancename": "RABEPRAZOLE SODIUM"
            },
            "openfda": {
              "application_number": [
                "NDA020973"
              ],
              "brand_name": [
                "ACIPHEX"
              ],
              "generic_name": [
                "RABEPRAZOLE SODIUM"
              ],
              "manufacturer_name": [
                "Waylis Therapeutics LLC"
              ],
              "product_ndc": [
                "80725-243"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "RABEPRAZOLE SODIUM"
              ],
              "rxcui": [
                "854868",
                "854870"
              ],
              "spl_id": [
                "cc6cb214-ac28-4c8b-9b57-7635ef896038"
              ],
              "spl_set_id": [
                "1eb38279-0237-4967-be7a-c53a826c1138"
              ],
              "package_ndc": [
                "80725-243-30"
              ],
              "unii": [
                "3L36P16U4R"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TOPAMAX",
            "drugstructuredosagenumb": "400",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "400 MG,ONCE IN THE MORNING",
            "drugindication": "SEIZURE",
            "activesubstance": {
              "activesubstancename": "TOPIRAMATE"
            },
            "openfda": {
              "application_number": [
                "NDA020505",
                "NDA020844"
              ],
              "brand_name": [
                "TOPAMAX"
              ],
              "generic_name": [
                "TOPIRAMATE"
              ],
              "manufacturer_name": [
                "Janssen Pharmaceuticals, Inc."
              ],
              "product_ndc": [
                "50458-639",
                "50458-640",
                "50458-641",
                "50458-642",
                "50458-647",
                "50458-645"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "TOPIRAMATE"
              ],
              "rxcui": [
                "151226",
                "151227",
                "151228",
                "151229",
                "152855",
                "199888",
                "199889",
                "199890",
                "205315",
                "205316",
                "845478",
                "845479"
              ],
              "spl_id": [
                "1c7483cf-95db-4b1c-ae4c-b11bc95a6ad8"
              ],
              "spl_set_id": [
                "21628112-0c47-11df-95b3-498d55d89593"
              ],
              "package_ndc": [
                "50458-639-65",
                "50458-640-65",
                "50458-641-65",
                "50458-642-65",
                "50458-647-65",
                "50458-645-65"
              ],
              "nui": [
                "N0000008486",
                "N0000185506",
                "N0000182140"
              ],
              "pharm_class_pe": [
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
              ],
              "pharm_class_moa": [
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Cytochrome P450 2C19 Inhibitors [MoA]"
              ],
              "unii": [
                "0H73WJJ391"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "YASMIN",
            "drugdosagetext": "UNK",
            "drugdosageform": "FILM-COATED TABLET",
            "drugstartdateformat": "602",
            "drugstartdate": "2005",
            "drugenddateformat": "602",
            "drugenddate": "2005",
            "activesubstance": {
              "activesubstancename": "DROSPIRENONE\\ETHINYL ESTRADIOL"
            },
            "openfda": {
              "application_number": [
                "NDA021098"
              ],
              "brand_name": [
                "YASMIN"
              ],
              "generic_name": [
                "DROSPIRENONE AND ETHINYL ESTRADIOL"
              ],
              "manufacturer_name": [
                "Bayer HealthCare Pharmaceuticals Inc."
              ],
              "product_ndc": [
                "50419-402"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "rxcui": [
                "284207",
                "748797",
                "748800",
                "748857"
              ],
              "spl_id": [
                "84c4a6e5-8157-4f6d-a51f-3665e8568a3c"
              ],
              "spl_set_id": [
                "d7ea6a60-5a56-4f81-b206-9b27b7e58875"
              ],
              "package_ndc": [
                "50419-402-03"
              ]
            }
          }
        ],
        "summary": {
          "narrativeincludeclinical": "CASE EVENT DATE: 200807"
        }
      }
    }
  ]
}